Rxivist logo

Author: David Cooper

  • Most recently observed institution: Pfizer Vaccine Research and Development, Pearl River, NY, USA

Rankings

  • All-time downloads: 303,774 (rank: 83 )
  • Categories:
    • infectious diseases: 203,210 (rank: 74 (tie) )
    • microbiology: 100,564 (rank: 136 (tie) )

Downloads per author, site-wide

Preprints

BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other Variants

microbiology more details view paper

No download data for this paper yet.

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

infectious diseases more details view paper
  • Downloaded 72,890 times
  • Download rankings, all-time:
    • Site-wide: 79
    • In infectious diseases: 29
  • Year to date:
    • Site-wide: 83
  • Since beginning of last month:
    • Site-wide: 192

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

infectious diseases more details view paper
  • Downloaded 70,201 times
  • Download rankings, all-time:
    • Site-wide: 84
    • In infectious diseases: 33
  • Year to date:
    • Site-wide: 277
  • Since beginning of last month:
    • Site-wide: 1,807

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera

microbiology more details view paper
  • Downloaded 58,333 times
  • Download rankings, all-time:
    • Site-wide: 104
    • In microbiology: 8
  • Year to date:
    • Site-wide: 17
  • Since beginning of last month:
    • Site-wide: None

Neutralization of spike 69/70 deletion, E484K, and N501Y SARS-CoV-2 by BNT162b2 vaccine-elicited sera

microbiology more details view paper
  • Downloaded 42,231 times
  • Download rankings, all-time:
    • Site-wide: 159
    • In microbiology: 13
  • Year to date:
    • Site-wide: 30
  • Since beginning of last month:
    • Site-wide: 2,733

Concurrent human antibody andTH1 type T-cell responses elicited by a COVID-19 RNA vaccine

infectious diseases more details view paper
  • Downloaded 23,625 times
  • Download rankings, all-time:
    • Site-wide: 329
    • In infectious diseases: 122
  • Year to date:
    • Site-wide: 669
  • Since beginning of last month:
    • Site-wide: 8,486

Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

infectious diseases more details view paper
  • Downloaded 21,177 times
  • Download rankings, all-time:
    • Site-wide: 370
    • In infectious diseases: 138
  • Year to date:
    • Site-wide: 77
  • Since beginning of last month:
    • Site-wide: 11

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans

infectious diseases more details view paper
  • Downloaded 15,317 times
  • Download rankings, all-time:
    • Site-wide: 532
    • In infectious diseases: 190
  • Year to date:
    • Site-wide: 165
  • Since beginning of last month:
    • Site-wide: 2,167

PanLingua

News